Brinda Balakrishnan

This profile gathers the share dealings of Brinda Balakrishnan in Aurinia Pharmaceuticals Inc. The record holds 3 filings, for trades running from 14 June 2021 to 21 May 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 23 May 2024, reports an option exercise in Aurinia Pharmaceuticals Inc. Typically, a trade is published a median of 6 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.